Doctors treating cancer patients nationwide are facing a shortage of essential generic chemotherapy drugs, a situation that many fear could lead to widespread rationing. The shortages stem from manufacturing problems, shipping delays and decisions by some companies to stop producing the medications, according to the Food and Drug Administration. The decades-old medicines are challenging to…
Many people undergoing chemotherapy experience a frustrating side effect often called “chemo brain.” These cognitive changes can include trouble concentrating, memory problems, and difficulty juggling multiple tasks. According to researchers, as many as 80% of chemotherapy patients experience some degree of cancer-related cognitive impairment. Now, a Phase II clinical trial suggests that two relatively simple…
The Food and Drug Administration said on Friday that it would permit some patients with deadly pancreatic cancer to receive early access to a promising, highly coveted drug. The treatment, daraxonrasib, taken as three pills a day, is not yet approved for use. But many patients have been desperate to try it. The drug recently…
